The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity (Q36404490)

14 August 2017

1 reference

title

The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity (English)

1 reference

14 August 2017

0 references

Dyck DJ

1

1 reference

PubMed ID

16497175

14 August 2017

Heigenhauser GJ

series ordinal

2

1 reference

PubMed ID

16497175

14 August 2017

Bruce CR

series ordinal

3

1 reference

14 August 2017

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

186

1 reference

14 August 2017

1

1 reference

14 August 2017

5-16

1 reference

Fat depot-specific expression of adiponectin is impaired in Zucker fatty rats

14 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Neutralization of tumor necrosis factor-alpha reverses insulin resistance in skeletal muscle but not adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

In vitro lipolytic effect of leptin on mouse adipocytes: evidence for a possible autocrine/paracrine role of leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Defective STAT signaling by the leptin receptor in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

AdipoQ is a novel adipose-specific gene dysregulated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Disruption of adiponectin causes insulin resistance and neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Overexpression of the obese (ob) gene in adipose tissue of human obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Peripheral metabolic actions of leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

A novel serum protein similar to C1q, produced exclusively in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Tumor necrosis factor induces rapid production of 1'2'diacylglycerol by a phosphatidylcholine-specific phospholipase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Direct antidiabetic effect of leptin through triglyceride depletion of tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

High-fat diet and leptin treatment alter skeletal muscle insulin-stimulated phosphatidylinositol 3-kinase activity and glucose transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Fatty acid oxidation and triacylglycerol hydrolysis are enhanced after chronic leptin treatment in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Endurance training partially reverses dietary-induced leptin resistance in rodent skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

The physiology of cellular liporegulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Comparative studies of resistin expression and phylogenomics in human and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Chronic leptin treatment normalizes basal glucose transport in a fiber type-specific manner in high-fat-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Chronic leptin treatment enhances insulin-stimulated glucose disposal in skeletal muscle of high-fat fed rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

TNF-alpha acutely inhibits vascular effects of physiological but not high insulin or contraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2005.01502.X

Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity

21 January 2018

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.2337/DIABETES.52.9.2191

Identifiers

DOI

10.1111/J.1748-1716.2005.01502.X

1 reference

14 August 2017

1 reference

PubMed ID

16497175